This page includes the latest FDA filings for Uqora Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Uqora Inc, Reese Pharmaceutical Co, Pharbest | Otc Medication | 2024-12-20 |
| Uqora Inc, Reese Pharmaceutical Co | Otc Medication | 2024-12-20 |
| UQORA INC, Pharbest | Otc Medication | 2024-12-19 |
| Uqora Inc, Reese Pharmaceutical Co, Pharbest | Otc Medication | 2022-12-30 |
| Uqora Inc, Reese Pharmaceutical Co | Otc Medication | 2022-12-30 |
| UQORA INC, Pharbest | Otc Medication | 2022-10-27 |
| UQORA INC | All-In-One UTI Emergency Kit | 2022-10-17 |
| Uqora Inc, Reese Pharmaceutical Co | Otc Medication | 2021-10-16 |
| Uqora Inc, Reese Pharmaceutical Co, Pharbest | Otc Medication | 2020-05-03 |
| Uqora Inc, Reese Pharmaceutical Co | Otc Medication | 2020-05-02 |
| Uqora Inc | Uqora Antibacterial Plus Urinary Pain Relief | 2020-04-29 |
| Uqora Inc | Uqora Maximum Strength Urinary Pain Relief | 2020-04-29 |
| NCAGE Code | 87ME0 | UQORA, INC.!DBA UQORA |
| CAGE Code | 87ME0 | UQORA, INC. UQORA |
| S.A.M. Registration | 87ME0 [116911860] | UQORA, INC. UQORA |
| DUNS | 116911860 | UQORA, INC. |
| SEC | 0001756772 | Uqora, Inc. of CALIFORNIA |